<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230318057752N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-11</date_registration>
      <primary_sponsor>Fasa University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Ocimum basilicum in anxiety</public_title>
      <acronym></acronym>
      <scientific_title>The comparison of the efficacy of hydroalcoholic extract of Ocimum basilicum and placebo in treatment of anxiety in depressed patients: A randomized double-blind clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69230</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization of participants is based on limited randomization, in which case the number of people in each group will be equal. For this purpose, we will remove 30 white balls and 30 black balls that represent each of the studied groups from the bag without replacement and write down their order. Then we put opaque and sealed envelopes containing black or white coded questionnaires into a box in the same order as the balls are removed. This box will be placed in the place where the researcher is visiting the patients participating in the study, and after the patient enters the study, the envelopes will be delivered to the patients in the same order of placement. After receiving the envelope, people will complete the questionnaires in another room. Medicines and placebos are placed in boxes with the same appearance and sealed in another room and are delivered to them according to the white or black code recorded in the patient's questionnaire. None of the people present in the study will be involved in the randomization and the type of medicine received by the patient. Each part of the study, such as randomization, observation of the color code of the questionnaires, and drug delivery, will be done by someone outside the study, Blinding description: After the visit of the patients by the psychiatrist, closed transparent envelopes containing the questionnaires will be given to the patients who wish to participate in the study. In another room, the patient will complete the questionnaires inside the envelopes, which have predetermined numbers. The colleague in the room gives the patient a box with the same code as the questionnaire, which contains medicine or placebo. With this method, the researchers will be unaware of the drug or placebo. Due to the similarity between the drug and the placebo, the patient will not know the difference between them. None of the people present in the study will be involved in the randomization and the type of medicine received by the patient.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Depression, anxiety.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: For four weeks, he consumes one tablespoon of Ocimum basilicum hydroalcoholic extract syrup at a dose of 220 mg/ml every night. This syrup will be produced by the order of Fasa University of Medical Sciences in the Faculty of Pharmacy of Shiraz University of Medical Sciences. Intervention 2: Control group: For four weeks, he consumes a tablespoon of placebo syrup every night, which has the same shape and packaging as Ocimum basilicum syrup. In order to prepare placebo simple syrup according to the American Pharmacopoeia, 85 grams of sugar is mixed with 100 ml of distilled water (similar to the base of medicinal syrup) and mixed slowly at a temperature of 100 degrees until it becomes uniform and with the help of permitted food coloring It should be the same color as medicinal syrup.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic information and clinical trial results

When:
6 months after the publication of the article, it will be possible to access the data.

To whom:
Researchers in all universities of medical sciences

Conditions:
The applicant should submit her request to the Vice-Chancellor of Research and Technology of Fasa University of Medical Sciences, and if this vice-chancellor and the ethics committee of this university agree, the data will be provided to applicant .

Where to obtain:
Fasa University of Medical Sciences, Vice President of Research and Technology

How to obtain:
Approval of the Research and Technology Vice-Chancellor and Ethics Committee of Fasa University of Medical Sciences

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kiarash Zare</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ibn Sina square, Fasa</address>
        <city>Fasa</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۷۴۶۱۶۸۶۶۸۸</zip>
        <telephone>+98 71 5335 0994</telephone>
        <email>kiarashzare1998@yahoo.com</email>
        <affiliation>Fasa University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Seyed Amin Kouhpayeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ibn Sina square, Fasa</address>
        <city>Fasa</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۷۴۶۱۶۸۶۶۸۸</zip>
        <telephone>0715335099</telephone>
        <email>kouhpayeha@gmail.com</email>
        <affiliation>Fasa University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Men and women between 18 and 65 years old
People with major depressive disorder based on DSM 5 criteria
Obtaining a minimum score of 18 in the Hamilton Anxiety Questionnaire
Not taking any new anti-anxiety medication in the last 1 month
Not suffering from significant internal diseases such as heart and lung failure, cancer, vascular disease, rheumatological disease, history of seizures and hypothyroidism, etc.
Not using anticoagulant or anti-platelet drugs such as warfarin, heparin, aspirin, etc.
No drug and alcohol addiction</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Any allergy to Ocimum basilicum and its products
Pregnancy or breastfeeding
Hypersensitivity to specific serotonin re-uptake inhibitor drugs
Patients who will not have proper follow-up</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F32</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, single episode</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For four weeks, he consumes one tablespoon of Ocimum basilicum hydroalcoholic extract syrup at a dose of 220 mg/ml every night. This syrup will be produced by the order of Fasa University of Medical Sciences in the Faculty of Pharmacy of Shiraz University of Medical Sciences.</i_keyword>
      <i_keyword>Control group: For four weeks, he consumes a tablespoon of placebo syrup every night, which has the same shape and packaging as Ocimum basilicum syrup. In order to prepare placebo simple syrup according to the American Pharmacopoeia, 85 grams of sugar is mixed with 100 ml of distilled water (similar to the base of medicinal syrup) and mixed slowly at a temperature of 100 degrees until it becomes uniform and with the help of permitted food coloring It should be the same color as medicinal syrup.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression score in Beck questionnaire. Timepoint: Before starting the study and 4 weeks after taking the drug. Method of measurement: Based on the Beck Depression Questionnaire.</prim_outcome>
      <prim_outcome>Anxiety score in Hamilton questionnaire. Timepoint: Before starting the study and 4 weeks after taking the drug. Method of measurement: Based on Hamilton anxiety questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Fasa University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-03-15</approval_date>
        <contact_name>Ethics committee of Fasa University of Medical Sciences</contact_name>
        <contact_address>Ibn Sina square, Fasa Fasa Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
